Affiliate disclosure: The RX Index earns a commission when you sign up with some of the providers mentioned on this page. It does not affect what you pay, and it never determines our rankings or which providers we cover. Read the full disclosure.
Weight Regain After Stopping Zepbound: What the Data Shows and What to Do Next
By The RX Index Editorial Team ·
The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. This article is for education, not medical advice. Your prescriber should guide any change to your Zepbound dose — stopping, lowering, spacing out shots, or restarting. We may earn a commission if you use some provider links below; it never changes your price or what we tell you.
Weight regain after stopping Zepbound is common — but it is not automatically “all the weight back,” and it is not your fault.
In the SURMOUNT-4 trial, adults lost about 20.9% of their body weight in the first 36 weeks on tirzepatide. The people who then switched to a placebo regained about 14% of their body weight over the next year. A post-hoc analysis of 308 withdrawal patients found that about 82.5% regained at least 25% of what they'd lost — but most stayed below their old starting weight, and almost 1 in 5 regained less than a quarter.
The 30-second version
| The question | The honest answer |
|---|---|
| Will I gain it all back? | Probably not all of it, but meaningful regain is common. Most people in the data stayed below their old starting weight. |
| How much, on average? | About 14% of body weight came back over a year after switching to placebo in SURMOUNT-4. |
| How common is regain? | About 82.5% of people who stopped regained at least 25% of what they'd lost. |
| Why does it happen? | The drug turns down appetite and "food noise." When it leaves your body, hunger comes back. The biology didn't change. |
| What helps most? | In the trials, staying on treatment beat stopping. A maintenance dose set by your doctor can be a middle path instead of quitting cold. |
| What should I do first? | Figure out why you're stopping. Then match the plan below. Don't change your dose alone. |
Weight regain after stopping Zepbound: will you really gain it all back?
When people stop a GLP-1 medication like Zepbound, the weight often creeps back. Maybe that's why you're here, a little scared, wondering if all that work was for nothing. It wasn't for nothing. And “the weight comes back” is too simple to be useful. Some people regain a little. Some regain a lot. The trial data shows a wide range, not one fate.
This page is for you if you are:
- • On Zepbound and getting close to your goal weight
- • Stopping because of price or insurance changes
- • Worried about regain after a missed refill
- • Thinking about lowering your dose instead of quitting
- • Trying to understand the real numbers before talking to your doctor
This page is NOT the right tool if you have:
- • Severe belly pain, vomiting, or signs of an allergic reaction — call your doctor now
- • A pregnancy or planned pregnancy — call your clinician today
- • An upcoming surgery — tell your surgery team about Zepbound first
How much weight do you regain after stopping Zepbound?
SURMOUNT-4, in plain English
SURMOUNT-4 was a study built to answer exactly this question. For the first 36 weeks, everyone took tirzepatide and lost an average of 20.9% of their body weight. Then the group was split. Half kept taking tirzepatide. Half switched to a placebo. Over the next 52 weeks, the placebo group regained about 14% of their body weight. The group that stayed on the drug lost another ~5.5%.
Put those together and the gap is huge. People who stayed on tirzepatide for the full 88 weeks were down about 25.3% from where they started. The people who stopped were still down about 9.9% — better than nothing, but a big difference. About 9 in 10 of the people who kept taking it held onto at least 80% of their weight loss. Among the people who stopped, only about 16.6% did.
This is the part almost every other page gets wrong — read it slowly:
- “14% of body weight” means a share of your whole body.
- “About half” means a share of the weight you lost.
Both describe the same finding. They use different starting points. If a page mixes these up, they don't fully understand the study.
How common was regain? (The exact breakdown)
That JAMA Internal Medicine analysis looked at 308 people who stopped tirzepatide after losing real weight. Here's how much they regained, measured as a share of the weight they'd lost:
| How much they regained (of weight lost) | Number of people | Share |
|---|---|---|
| Less than 25% | 54 | 17.5% |
| 25% to under 50% | 77 | 25.0% |
| 50% to under 75% | 103 | 33.4% |
| 75% or more | 74 | 24.0% |
| At least 25% (the three lower rows combined) | 254 | 82.5% |
Two things jump out. First, regain was common — about 82.5% gave back at least a quarter of their loss. Second, it was not the same for everyone. Almost 1 in 5 regained less than 25%. The study also found that the more weight people regained, the more their health gains — blood pressure, cholesterol, blood sugar — slid back too.
What that looks like in your own pounds
Percentages are slippery. Pounds are real. Find the row closest to how much you've lost:
| If you lost… | A 25% regain = | A 50% regain = | A 75% regain = |
|---|---|---|---|
| 20 lb | 5 lb | 10 lb | 15 lb |
| 40 lb | 10 lb | 20 lb | 30 lb |
| 60 lb | 15 lb | 30 lb | 45 lb |
| 80 lb | 20 lb | 40 lb | 60 lb |
| 100 lb | 25 lb | 50 lb | 75 lb |
Say you lost 60 pounds. A 25% regain is 15 pounds back — still 45 pounds down from where you started. A 75% regain is 45 pounds back. Same person, very different outcomes. The numbers are not a sentence. They're a reason to make a plan instead of winging it.
See what these scenarios mean for your weight
Answer a few quick questions about how much you've lost and why you're stopping. We'll show your regain scenarios and a checklist to bring to your prescriber. Free · about 60 seconds · no signup.
Get my free personalized stop-plan →Why does the weight come back after stopping Zepbound?
It was never “willpower in a pen”
Tirzepatide isn't a stimulant or a “burn fat” drug. It works on hormone signals your body already uses. Per Zepbound's FDA prescribing information, it turns on GIP and GLP-1 receptors and lowers how many calories you eat, likely by reducing appetite. In plain terms: it makes you feel full sooner and think about food less.
That “thinking about food less” feeling has a nickname. People call it losing the food noise. When the drug clears, that noise tends to come back — and many people say it comes back even stronger than before. The appetite control fades when the medication does. That's the engine behind regain. Not weakness. Hormones.
| What the label says the drug does | What that means after you stop | What to keep an eye on |
|---|---|---|
| Activates GIP and GLP-1 receptors that help control appetite | That appetite help fades | How hungry you feel; how loud the food noise gets |
| Lowers how many calories you eat | What you eat can drift upward | Meal structure and portion sizes |
| Slows how fast your stomach empties | You may feel full for less time | How satisfied you feel after meals |
Doesn't eating well protect me?
Good habits help. But they may not fully replace the drug. Here's the key fact people miss: the people in SURMOUNT-4 were getting diet and exercise counseling the whole time. They had support. And many of them still regained weight after switching to placebo. If your plan is “I'll just keep eating clean and I'll be fine,” understand that the data says habits matter but the regain risk is still real. This is why doctors increasingly treat obesity like a long-term condition, not a problem you fix once.
The fear underneath all of this
A lot of people land on this page asking some version of the same quiet question: “Was this all for nothing?”No. You learned what your body feels like with hunger turned down. You know what fullness feels like now. That knowledge doesn't vanish. And the data is clear that even people who regained some weight mostly stayed below their old starting point. You're not back to square one. You're at a decision point.
How long does Zepbound stay in your system after your last dose?
Half-life, explained simply
“Half-life” is just the time it takes your body to clear half of one dose. For tirzepatide, that's roughly 5 to 6 days. Here's the rough math, using a 5-day half-life:
| Days since your last dose | About how much is left |
|---|---|
| 0 (dose day) | 100% |
| 5 | 50% |
| 10 | 25% |
| 15 | ~12% |
| 20 | ~6% |
| 25 | ~3% |
| 30 | ~2% |
| Simple half-life math, not a symptom timeline or personal prediction. Your appetite won't follow this chart exactly. | |
A simple monitoring plan, not a fake symptom timeline
Be careful with any page that promises “Day 7 you'll feel X, Day 14 you'll feel Y.” Nobody can know your exact timeline. What we can give you is a smart way to watch:
- Week 1Stay consistent. Don't panic over a normal scale bounce. Water weight wobbles.
- Weeks 2–4Start tracking three things — your weight trend (not single days), your hunger, and how loud the food noise is getting.
- Weeks 5–8Look at the trend line, not one weigh-in. Is it flat, or climbing?
- Weeks 9–12Decision time. If the trend is rising, this is when you talk to your prescriber about restarting, a maintenance dose, or another option.
What if I only missed one Zepbound dose?
Can you stop Zepbound without gaining weight?
About 17.5% of people who stopped regained less than 25% of what they'd lost. So yes — stopping without much regain is possible. It happens. But about 82.5% regained at least a quarter of their loss. Both numbers are true. Plan for the likely case, and hope for the good one.
Set your personal “trigger” before you stop
Pick the number that will tell you to act, in advance, before emotion clouds it. In the JAMA Internal Medicine analysis, a 25% regain was the line researchers treated as meaningful — the point where health gains started slipping. So if you lost 60 pounds, your 25% mark is 15 pounds. Decide now: “If I'm up 15 pounds, I call my prescriber.” Then ask your doctor what your personal trigger should be.
Early warning signs your plan isn't holding
Watch for these. If a few show up together, it's time to call your prescriber:
- ▲Your weight trends up across several weeks (not one bad day).
- ▲The food noise comes roaring back and feels hard to manage.
- ▲You're having more "loss of control" eating moments.
- ▲Your waist measurement is climbing.
- ▲If you have sleep apnea, blood pressure issues, or blood sugar concerns, those start slipping.
- ▲You're avoiding the scale because you already know what it'll say.
Should you taper, lower your dose, or stop Zepbound all at once?
What the newest evidence shows
A 2026 maintenance trial called SURMOUNT-MAINTAIN tested this exact question. After people lost weight on a full dose, they were split into three groups: stay on the full dose, drop to a lower 5 mg dose, or stop. Results from that two-year window:
- Full dose continuedDown ~21.9% from starting weight
- Lower 5 mg maintenance doseDown ~16.6% from starting weight
- StoppedDown ~9.9% from starting weight
The takeaway is clear: a lower maintenance dose kept off much more weight than stopping — even though the full dose held the most. That's real evidence that a maintenance dose can be the middle path.
What is the Zepbound maintenance dose after weight loss?
A “maintenance dose” is the steady weekly dose you take after you reach your goal, to hold your results. Zepbound's prescribing information lists 5 mg, 10 mg, or 15 mg once a week as maintenance doses, chosen based on how you responded and how well you tolerate it. The 2.5 mg starter dose is not a maintenance dose. Your clinician sets the right one for you.
What the evidence does not prove
| What the label and trials show | What they do not prove |
|---|---|
| 5 mg, 10 mg, and 15 mg are maintenance doses | There's no universal "taper" recipe that prevents regain |
| Doctors pick the dose based on response and tolerance | The label doesn't say everyone should drop their dose at goal weight |
| A lower 5 mg dose beat stopping in SURMOUNT-MAINTAIN | It doesn't show that stretching out your own shots prevents regain |
Bring these questions to your prescriber
- ✓Is my goal to maintain, to lose more slowly, or to stop completely?
- ✓Am I a candidate for a lower maintenance dose like 5 mg?
- ✓If I stop, what weight trend should make me call you?
- ✓If I restart after a break, do I need to step back up from a lower dose?
- ✓Are my side effects a reason to stop, lower the dose, or look for another cause?
- ✓Do I still need my current dose?
A one-page guide you can hand your doctor — built around your reason for stopping. Use it before you change your dose, space out your shots, or stop.
Get my free Zepbound prescriber question checklist →What if you're stopping Zepbound because it's too expensive?
“I can't afford it” and “I should stop” are two different problems. Let's lower the cost first.
Current Zepbound savings and access routes
Prices change often — confirm the current numbers the day you act.
| Route | Stated price | What we verified | The catch | Last verified |
|---|---|---|---|---|
| Commercial insurance covers it + Lilly savings card | As low as $25/month | Lilly savings page | Card expires 12/31/2026; monthly caps apply | ⚠ |
| Cash-pay single-dose vials (LillyDirect (sponsored affiliate link, opens in a new tab)) | About $299–$449/month by dose | Lilly / LillyDirect | Lower doses cost less; you draw the dose with a syringe; lowest price on higher doses needs refill within 45 days | ⚠ |
| Commercial insurance does not cover it + savings card | As low as $499/month (pen) | Lilly savings page | Not for government plans; terms apply | ⚠ |
| HSA/FSA dollars | Lowers cost using pre-tax money | Standard HSA/FSA rules | Payment method, not a discount; savings depend on your tax bracket |
If you need help getting access or fighting insurance
Ro carries FDA-approved Zepbound (tirzepatide) and the new oral pill Foundayo (orforglipron). It has a free GLP-1 Insurance Coverage Checker and an insurance team that files prior-authorization paperwork and appeals for you. Ro reports that, among its coverage-checker users, 43% had GLP-1 coverage for weight loss — and of those, about half paid $50 a month or less.
Pricing: Ro Body costs $39 for the first month, then $149/month, or as low as $74/month with annual prepay; the GLP-1 medication is billed separately. For cash-pay, Ro currently lists Zepbound at about $299/month for the 2.5 mg dose, $399 for 5 mg, and $449 for 7.5–15 mg with the manufacturer offer. (Verify current Ro pricing before you act.)
Cost is your only blocker and you want to stay on real Zepbound?
See whether Ro can verify your insurance, handle the paperwork, and show your real monthly cost — before you stop.
Check Zepbound access and coverage with Ro → (sponsored affiliate link, opens in a new tab)Disclosure: Some links on this page are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you.
On Medicare? See the Medicare GLP-1 Bridge details below.What if your insurance stopped covering Zepbound after you lost weight?
Coverage swings both ways — a real, recent example
In July 2025, CVS Caremark dropped Zepbound from its standard commercial drug list. Thousands of patients had to scramble. One analysis found monthly switching away from tirzepatide jumped from about 0.6% to 10.2% right after. Then, after patient backlash, CVS reversed course. On , CVS announced it will bring Zepbound back as a covered option starting — a template covering roughly 25 to 30 million Americans. (Source: CVS Health; Boston Globe.) Because “my plan stopped covering it” today does not mean “covered never again.”
Figure out why you were denied — then act
| The denial reason | What it means | What to ask for |
|---|---|---|
| Plan exclusion | Your plan doesn't cover weight-loss drugs at all | Whether a related condition (like sleep apnea) opens a different door |
| Prior authorization needed | Your doctor must send paperwork first | Your prescriber to file the PA with your history and BMI |
| Step therapy | You must try a cheaper drug first | Whether you've already "failed" the required drug, which can satisfy this |
| BMI or criteria not met | Your records don't show you qualify | Updated documentation of BMI and any weight-related conditions |
| Formulary change | The plan dropped it this year | Whether a reversal is coming, or an appeal/exception is possible |
| Wrong indication coded | It was billed for the wrong reason | Your clinician to confirm the correct, covered indication |
Use this if you're stopping because your plan changed — not because your prescriber told you to. It walks you through your denial reason and the fastest routes to keep coverage.
Get my free coverage-and-appeal checklist →Does the Medicare GLP-1 Bridge cover Zepbound?
Yes — but only the KwikPen form, and only for weight loss.
Starting , eligible Medicare Part D members can get certain GLP-1 drugs for a flat $50/month copay through the Medicare GLP-1 Bridge, running through . For Zepbound, the program covers the KwikPen version only — the single-dose vials and single-dose pens are not included. (Zepbound for moderate-to-severe sleep apnea is handled through regular Part D, not the Bridge.)
You must be enrolled in Part D and meet health rules (generally BMI ≥35, or ≥27 with another condition). The $50 copay doesn't count toward your deductible or annual out-of-pocket cap. Note: Ro doesn't coordinate government-plan coverage, so the Bridge is a separate path from the Ro route above.
Stopping for side effects, pregnancy, or surgery? Read this first.
Side effects, pregnancy, and surgery are safety decisions, not shopping decisions.
If any of these is your reason, the move is to talk to your prescriber or care team now — not to follow a self-guided plan, and not to click a provider link. We are deliberately not putting a “sign up here” button in this section.
The boxed warning and who should not take Zepbound
Zepbound carries a boxed warning — the FDA's strongest — for a risk of thyroid C-cell tumors (seen in animal studies). It should not be used by people with a personal or family history of medullary thyroid carcinoma (MTC), people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or anyone with a known serious allergy to tirzepatide. If any of those apply, restarting or continuing is a conversation with your clinician — full stop.
Pregnancy or trying to conceive
Zepbound's label says weight loss offers no benefit during pregnancy and may harm a developing baby, and to stop Zepbound once pregnancy is recognized. There's a second thing many people don't know: because Zepbound slows stomach emptying, it may make birth control pills work less well. The label advises switching to a non-pill method, or adding a barrier method (like condoms), for 4 weeks after starting and for 4 weeks after each dose increase.
Severe side effects
Don't use this page — or any web page — as an emergency tool. Zepbound's label warns about serious issues including pancreatitis (severe, lasting belly pain), gallbladder problems, kidney injury from dehydration after vomiting or diarrhea, and serious allergic reactions. If you're having severe or scary symptoms, that's a call to your doctor or urgent care, not a Google search.
Surgery or anesthesia
A practical 90-day plan for after you stop Zepbound
Before your last dose
- •Write down your current weight and your lowest weight.
- •Measure your waist.
- •Note your current dose and the date of your last shot.
- •Write down — in one sentence — why you're stopping.
- •Confirm your prescriber's instructions.
- •Ask which weight trend should trigger a follow-up call.
- •Sort out cost and coverage before the gap starts.
Weeks 1–4
- •Don't overreact to a normal scale bounce.
- •Keep your meal structure steady — especially protein.
- •Track your hunger and food noise. Notice changes; don't judge them.
- •Keep up strength training if your clinician says it's okay.
- •Keep that follow-up on the calendar.
Weeks 5–8
- •Watch the trend line, not one weigh-in.
- •Check in on cravings and fullness honestly.
- •Adjust with help from your clinician or a dietitian.
- •If cost was your reason, revisit savings and coverage now, before any regain grows.
Weeks 9–12: Your checkpoint
- •Stable and your clinician agrees? Stay off, keep monitoring.
- •Trend rising? Talk about restarting.
- •Want long-term management? Ask about a maintenance dose.
- •The real problem was cost or coverage? Look at another FDA-approved access path.
You don't have to figure out which lane is yours alone. Our quiz routes you based on your reason for stopping and your numbers.
Get your personalized GLP-1 stop plan →When should you ask about restarting, continuing, or switching?
Continuing — just through a different door
If your blocker is cost, paperwork, or insurance, you don't need to stop. Here's how the main FDA-approved paths compare:
| Access path | Best fit | What it can and can't do |
|---|---|---|
| LillyDirect (sponsored affiliate link, opens in a new tab) | You already have a prescriber and want the lowest cash price | Sells real Zepbound vials direct from Lilly; doesn't fight your insurance for you |
| Ro | You want insurance help and a care team in one place | Carries Zepbound; files PAs and appeals; charges a membership; no government plans |
| Sesame (sponsored affiliate link, opens in a new tab) | You want to pick your provider | Offers FDA-approved options and some Costco-member pricing; medication billed separately ⚠ verify |
| Medicare GLP-1 Bridge | You're on Medicare Part D and qualify | $50/month for the Zepbound KwikPen; weight-loss use only; runs through 2027 |
| Your current prescriber | You're already established with a doctor | Can adjust dose, document need, and guide a maintenance plan |
Why compounded tirzepatide is not “just Zepbound”
Is stopping Zepbound different from stopping Wegovy or Ozempic?
For semaglutide (the drug in Wegovy and Ozempic), an extension of the STEP 1 trial found people regained about two-thirds of their lost weight within a year of stopping. Different drug, different number, same story: these medicines treat a long-term condition, and stopping tends to reverse the benefit.
See also: What Happens When You Stop Wegovy? and our guide to GLP-1 Weight Regain: 2026 Data & Stop Plan for the broader picture across all GLP-1s.
What we actually verified for this guide
We don't expect you to take our word for it. Here's exactly what we checked, when, and what would make it change. That's how an honest resource works.
| What we checked | Source | Last verified | What would change it |
|---|---|---|---|
| SURMOUNT-4 continue-vs-stop results (14% regain, 5.5% extra loss) | JAMA (clinical trial) | New trial or correction | |
| The regain breakdown (82.5% regained ≥25%; ~9% over 100%) | JAMA Internal Medicine (post-hoc analysis) | New maintenance/withdrawal evidence | |
| Lower-dose maintenance results | SURMOUNT-MAINTAIN (The Lancet, 2026) | New maintenance evidence | |
| Zepbound dosing, maintenance doses, boxed warning, pregnancy guidance | FDA / Eli Lilly prescribing information | A label update | |
| Zepbound half-life (~5-6 days, ~30 days to clear) | FDA / Eli Lilly prescribing information | A label update | |
| Lilly savings card and LillyDirect vial pricing | Eli Lilly / LillyDirect | Changes monthly -- re-verify | |
| Ro pricing, formulary, insurance checker | Ro official pages | Changes monthly -- re-verify | |
| CVS Caremark reinstating Zepbound (Oct 1, 2026) | CVS Health newsroom; Boston Globe; NBC | Plan/PBM updates | |
| Medicare GLP-1 Bridge ($50/month, KwikPen only) | CMS; KFF | CMS guidance update | |
| Sesame / Costco access details | Sesame / Costco | Changes monthly |
We did not complete a prescription purchase. Your eligibility, state availability, final price, and the right medical plan must be confirmed with a clinician and the provider.
Frequently asked questions
About weight regain after stopping Zepbound.
Will I gain all the weight back after stopping Zepbound?
Probably not all of it, but meaningful regain is common. In the post-hoc analysis of SURMOUNT-4, about 82.5% of people who stopped tirzepatide regained at least a quarter of the weight they had lost within a year -- but most still stayed below their old starting weight, and almost 1 in 5 regained less than 25%.
How fast does weight regain start after stopping Zepbound?
The trial data reports outcomes over months, not a guaranteed week-by-week pattern. Zepbound's half-life is about 5 to 6 days, and the drug is mostly gone in about 30 days, so the first month is a sensible window to watch your weight trend, hunger, and food noise closely.
Do you have to stay on Zepbound forever?
Not necessarily, but it's labeled for long-term weight maintenance, and stopping often leads to regain. Instead of stopping cold, your prescriber may discuss staying on a maintenance dose. The right choice is individual.
Is there a maintenance dose for Zepbound?
Yes. Zepbound's prescribing information lists 5 mg, 10 mg, or 15 mg once weekly as maintenance doses for keeping weight off, chosen based on your response and tolerability. The 2.5 mg starter dose is not a maintenance dose.
Can I just lower my dose instead of stopping?
Possibly -- a lower maintenance dose is a common middle path, and a 2026 trial found a 5 mg dose kept off much more weight than stopping. But that's a prescriber decision. Don't reduce or change your dose on your own.
Can I taper off Zepbound to avoid regain?
There's no official taper recipe proven to prevent regain. A lower, doctor-managed maintenance dose has evidence behind it; stretching out your own shots does not. Talk to your prescriber before changing anything.
What if my insurance stopped covering Zepbound?
Don't assume quitting is your only option. Read your denial reason, ask your prescriber about documenting continued need, and check savings cards, appeals, and FDA-approved alternatives. Coverage can also be reinstated -- CVS Caremark is adding Zepbound back to its standard commercial list on October 1, 2026.
Does Medicare cover Zepbound?
In two ways. Starting July 1, 2026, eligible Part D members can get the Zepbound KwikPen for a $50/month copay through the Medicare GLP-1 Bridge (weight-loss use; runs through 2027). Zepbound is also coverable under standard Part D when prescribed for moderate-to-severe sleep apnea in adults with obesity.
How long does Zepbound stay in your system?
About 30 days -- roughly a month -- after your last dose, based on a half-life of about 5 to 6 days, per Zepbound's prescribing information. That's a practical estimate; appetite and weight changes don't follow an exact calendar.
Can I stop Zepbound for pregnancy?
This needs your clinician's guidance. Zepbound's label says weight loss isn't recommended during pregnancy and to stop the drug once pregnancy is recognized. It can also reduce the effectiveness of birth control pills, so ask about backup methods.
Is compounded tirzepatide the same as Zepbound?
No. Zepbound is an FDA-approved, brand-name medication. Compounded tirzepatide is custom-mixed and not FDA-approved, and the FDA has warned that some unapproved GLP-1 products may be counterfeit or contain the wrong amount of active ingredient.
What should I do before my last dose?
Write down your current and lowest weight, your waist measurement, your dose, your last-dose date, and your reason for stopping. Confirm your prescriber's instructions, then follow a 90-day plan to track your trend and know when to follow up.
Still deciding? Start here.
You came here scared the answer was “you'll gain it all back.” The real answer is more hopeful and more useful: regain is common, but it's not your fate, and what you do next is yours to shape.
Tell us how much you've lost and why you're stopping. We'll show your regain scenarios, build your 90-day plan, and point you to the right next step — continue, maintain, restart, or switch. Free · 60 seconds · no signup.
Get your personalized GLP-1 stop plan →